[
  {
    "ts": null,
    "headline": "Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy",
    "summary": "Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=7bfc47fb26b4a2fa6eb380a666ecfb0728da7ae4892f85439ccf16e1033ef008",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736725535,
      "headline": "Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy",
      "id": 132384724,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183826211/image_183826211.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=7bfc47fb26b4a2fa6eb380a666ecfb0728da7ae4892f85439ccf16e1033ef008"
    }
  }
]